DK1041984T3 - Drikbart farmaceutisk præparat - Google Patents

Drikbart farmaceutisk præparat

Info

Publication number
DK1041984T3
DK1041984T3 DK98963579T DK98963579T DK1041984T3 DK 1041984 T3 DK1041984 T3 DK 1041984T3 DK 98963579 T DK98963579 T DK 98963579T DK 98963579 T DK98963579 T DK 98963579T DK 1041984 T3 DK1041984 T3 DK 1041984T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparation
drinkable pharmaceutical
drinkable
preparation
pharmaceutical
Prior art date
Application number
DK98963579T
Other languages
English (en)
Inventor
Claude Aleman
Philippe Bastard
Marielle Bonnel
Thierry Breul
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of DK1041984T3 publication Critical patent/DK1041984T3/da

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
DK98963579T 1997-12-24 1998-12-14 Drikbart farmaceutisk præparat DK1041984T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9716529A FR2772614B1 (fr) 1997-12-24 1997-12-24 Solution aqueuse a base de chlorhydrate de 1- [ 2-(2-naphtyl)ethyl]-4- (3-trifluoromethylphenyl) -1,2,3,6-tetrahydropyridine et composition pharmaceutique buvable en contenant
PCT/FR1998/002712 WO1999033466A1 (fr) 1997-12-24 1998-12-14 Composition pharmaceutique buvable

Publications (1)

Publication Number Publication Date
DK1041984T3 true DK1041984T3 (da) 2004-02-16

Family

ID=9515152

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98963579T DK1041984T3 (da) 1997-12-24 1998-12-14 Drikbart farmaceutisk præparat

Country Status (25)

Country Link
US (1) US6191137B1 (da)
EP (1) EP1041984B1 (da)
JP (1) JP2002510599A (da)
AR (1) AR017722A1 (da)
AT (1) ATE252384T1 (da)
AU (1) AU1880599A (da)
BR (1) BR9814414A (da)
CA (1) CA2315696C (da)
CO (1) CO4970813A1 (da)
DE (1) DE69819203T2 (da)
DK (1) DK1041984T3 (da)
DZ (1) DZ2676A1 (da)
ES (1) ES2209238T3 (da)
FR (1) FR2772614B1 (da)
GT (1) GT199800204A (da)
HU (1) HUP0101012A3 (da)
MY (1) MY117156A (da)
NO (1) NO20003284L (da)
PT (1) PT1041984E (da)
SA (2) SA99191003B1 (da)
SI (1) SI1041984T1 (da)
TW (1) TW536409B (da)
UY (1) UY25320A1 (da)
WO (1) WO1999033466A1 (da)
ZA (1) ZA9811824B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070053883A1 (en) * 2003-03-25 2007-03-08 The Johns Hopkins University Neuronal cell lineages and methods of production thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2702656B1 (fr) * 1993-03-18 1995-06-16 Sanofi Elf Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments cardioprotecteurs.

Also Published As

Publication number Publication date
DE69819203D1 (de) 2003-11-27
TW536409B (en) 2003-06-11
NO20003284D0 (no) 2000-06-22
AU1880599A (en) 1999-07-19
CO4970813A1 (es) 2000-11-07
ZA9811824B (en) 1999-06-29
CA2315696A1 (en) 1999-07-08
ES2209238T3 (es) 2004-06-16
HUP0101012A3 (en) 2002-12-28
DZ2676A1 (fr) 2004-09-19
MY117156A (en) 2004-05-31
DE69819203T2 (de) 2004-07-15
SI1041984T1 (en) 2004-04-30
FR2772614B1 (fr) 2000-03-10
GT199800204A (es) 2000-06-14
EP1041984A1 (fr) 2000-10-11
FR2772614A1 (fr) 1999-06-25
US6191137B1 (en) 2001-02-20
BR9814414A (pt) 2000-10-10
SA99191002B1 (ar) 2006-03-07
AR017722A1 (es) 2001-09-12
HUP0101012A2 (hu) 2001-08-28
PT1041984E (pt) 2004-02-27
EP1041984B1 (fr) 2003-10-22
WO1999033466A1 (fr) 1999-07-08
SA99191003B1 (ar) 2006-10-02
JP2002510599A (ja) 2002-04-09
NO20003284L (no) 2000-08-24
CA2315696C (en) 2008-01-29
UY25320A1 (es) 2000-10-31
ATE252384T1 (de) 2003-11-15

Similar Documents

Publication Publication Date Title
NO20001776D0 (no) Medikamenter
FI970038A (fi) Kosteuttava valmiste
IS4974A (is) Lyfjasamsetning á þrýstingsúðaformi
ID24654A (id) Formulasi farmasi omeprazola
DK1466615T3 (da) Farmaceutisk præparat
NO980546D0 (no) Farmasöytiske midler
DK1017392T3 (da) Lægemiddel
IS5331A (is) Ný lyfjablanda
NO20010089D0 (no) Farmasöytisk levotyroksinpreparat
ID29294A (id) Komposisi farmasi
ZA982073B (en) Pharmaceutical preparation
DE69926012D1 (de) Arzneizubereitungen
ID25857A (id) Komposisi farmasi
FI951155A0 (fi) Farmaseuttinen valmiste
DE69906934D1 (de) Arzneizubereitungen
DE69809375T2 (de) Antikrebs-Zubereitung
DK1041984T3 (da) Drikbart farmaceutisk præparat
DE29719974U1 (de) Getränk
DE29721934U1 (de) Getränk
ID23531A (id) Komposisi farmasi
ID23663A (id) Persiapan kaprolaktam
DE29722695U1 (de) Kanne
DE29618094U1 (de) Pharmazeutisches Präparat
DE69904021D1 (de) Flüsige pharmazeusche zubereitung enthaltend zotepin
FI3862U1 (fi) Geelimuotoinen farmaseuttinen valmiste